Home > Drug Search >
  • company_query: ADMA Biologics
  •   > 
Drug Filter
Category:
chemistry (3) biology (52)
Status:
Approved (5) BLA Filing (4) Phase Ⅲ (7) Phase Ⅱ (27) Phase Ⅰ (12)
Clinical Stage:
Pending (7) Active (38) Discontinued (5)
Bio-Type:
Gene therapy (1) Vaccine (19) Blood extraction (2) Animal extract (1) Recombinant enzyme (2) Recombinant polypeptide (1) Recombinant cytokines (1) Recombinant hormone (2) Whole antibody (9) Fab fragment (2) ADC (1) Fusion protein (6)
Indication:
Non-alcoholic steatohepatitis (1) Acute myeloid Leukemia (AML) (1) Anemia (2) Breast cancer (2) Rectal cancer (1) Chronic lymphocytic leukemia (CLL) (1) Guillain-Barre syndrome (1) Avian influenza (1) Diabetic nephropathy (1) Duchenne muscular dystrophy (DMD) (1) Rheumatic disorders (1) Transplant rejection (1) Gastric cancer (1) Wet age-related macular degeneration (2) HBV infection (2) Alcoholic hepatitis (1) Hepatocellular carcinoma (HCC) (1) HIV infection (6) Influenza virus infection (2) Somatotropin deficiency (1) Rabies (2) Renal osteodystrophy (1) Multiple myeloma (MM) (1) Multiple sclerosis (MS) (1) Myelodysplastic syndrome (MDS) (2) Myocardial infarction (MI) (1) Non small cell lung cancer (NSCLC) (1) Pancreatic cancer (3) Peripheral  neuropathy (1) Cellulite (1) Renal cell carcinoma (1) Solid tumours (6) Systemic lupus erythematosus (1) Typhoid (1) Tuberculosis (1) Type 2 diabetes (1) Yellow fever (1) Metamfetamine abuse (1) Head and neck cancer (1) Influenza A virus infections (1) Colorectal cancer (1) Cryopyrin-Associated Periodic Syndromes (CAPS) (1) Pneumocystis pneumonia (1) Chronic heart failure (1) Anthrax (1) Age-related macular degeneration (AMD) (1) Stroke (1) Autistic disorder (1) Diabetes (1) Malaria (1) Sickle cell disease (1) Type 1 diabetes (1) Infertility (1) Glioblastoma (2) Graft versus host disease (2) Respiratory syncytial virus infection (2) Thelassemia (2) Vascular calcification (1) Immunodeficiency disorders (2) Ebola virus disease (EVD) (3) Alpha-1 antitrypsin deficiency (1) Immune thrombocytopenic purpura (1)
Aprv. Year:
Others:
Sort: Aprv. Year Alphabetical Prev Next
First Prev 1 2 3 Next Last GO
Recently Viewed Drugs:
Insert title here
Feed-Back To Top
ICP Permit 14047345| Beijing PSB Hai Dian Record 11010802017043 |(京)-经营性-2015-0023(互联网药品信息服务资格证书)
Insert title here
Feed-Back To Top